Crossmark

Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

Crossref DOI link: https://doi.org/10.1007/s12307-015-0165-y

Published Online: 2015-02-05

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vogelhuber, M.

Feyerabend, S.

Stenzl, A.

Suedhoff, T.

Schulze, M.

Huebner, J.

Oberneder, R.

Wieland, W.

Mueller, S.

Eichhorn, F.

Heinzer, H.

Schmidt, K.

Baier, M.

Ruebel, A.

Birkholz, K.

Bakhshandeh-Bath, A.

Andreesen, R.

Herr, W.

Reichle, A.
License Information

Text and Data Mining valid from 2015-02-05

Document is current

Any future updates will be listed below